A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression

Clinical trial NCT01230710 · COMPLETED

Trial details

NCT number

NCT01230710

Sponsor

Hoffmann-La Roche

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2011-03-01

Primary completion

2013-09-01

Enrollment

51

View on ClinicalTrials.gov